MYBL2 and neoplasm: However, our syngeneic intraovarian mouse models demonstrated that MYBL2 failed to induce intratumoral and ascitic trafficking of TAMs and facilitated tumor progression upon LC treatment, indicating that the tumor-promoting mechanisms of MYBL2 largely depended on TAMs.